Live Breaking News & Updates on Jayaprakash Muliyil

Stay updated with breaking news from Jayaprakash muliyil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Why High Antibody Doesn't Guarantee Protection From Covid-19?


Why High Antibody Doesn’t Guarantee Protection From Covid-19
Doctors say that the amount of antibodies that vaccination will produce in an individual depends on his or her immune system.
Jeevan Prakash Sharma
10 May 2021, Last Updated at 7:05 pm
File photo
Jeevan Prakash Sharma
2021-05-10T12:07:43+05:30
Why High Antibody Doesn’t Guarantee Protection From Covid-19
outlookindia.com
2021-05-10T19:05:51+05:30
Also read
The purpose of the current vaccination drive is to provide protection from Sars Cov 2 that causes Covid-19. However, in the second wave, many such cases have come up in which people have contracted the virus a few weeks after taking both doses of vaccines. A few of them have died also. ....

West Bengal , Uttar Pradesh , Gyaneshwar Chaubey , Syamal Roy , Jayaprakash Muliyil , Samratd Shah , Indian Institute Of Chemical Biology , Head Of The Department Infectious Diseases , Banaras Hindu University , Infectious Diseases , Indian Institute , Chemical Biology , மேற்கு பெங்கல் , உத்தர் பிரதேஷ் , கியனெஷ்வார் சௌபேய் , சியாமல் ராய் , இந்தியன் நிறுவனம் ஆஃப் இரசாயன உயிரியல் , தலை ஆஃப் தி துறை தொற்று நோய்கள் , பனாரஸ் இந்து பல்கலைக்கழகம் , தொற்று நோய்கள் , இந்தியன் நிறுவனம் , இரசாயன உயிரியல் ,

'Mumbai model': Indian city thwarting COVID, slowly but steadily | Coronavirus pandemic News


Mumbai, India – Till the end of last month, 27-year-old Ashish Avhad had to field non-stop telephone calls from COVID patients seeking beds, ambulances and guidance on home isolation.
Avhad works as a telephone operator in one of the 24 COVID response “war rooms” in India’s financial capital Mumbai, home to more than 12.5 million people, in the western state of Maharashtra.
As the city was swept by a raging second wave of the virus and cases peaked in April, Avhad remembers handling more than 100 calls a day during his eight-hour shift.
“Every second call would be a distress call,” said Avhad, a civil engineer who became a telephone operator after losing his job in the pandemic. ....

New Delhi , Jayaprakash Muliyil , Suresh Kakani , Ashish Avhad , Iqbal Singh Chahal , Bombay Municipal Corporation , India Supreme Court , Al Jazeera , Supreme Court , Medical Oxygen , High Flow Nasal Oxygen , Mumbai But Chahal , Additional Municipal Commissioner Suresh Kakani , புதியது டெல்ஹி , சுரேஷ் ககானி , இக்ப்யால் சிங் சாஹல் , குண்டு நகராட்சி நிறுவனம் , இந்தியா உச்ச நீதிமன்றம் , அல் ஜஜீர , உச்ச நீதிமன்றம் , மருத்துவ ஆக்ஸிஜந் , உயர் ஓட்டம் நாசி ஆக்ஸிஜந் ,

Covid Vaccines Speed Up Production Of Antibodies In Those Who Have Recovered From Infection: BHU Study


Covid Vaccines Speed Up Production Of Antibodies In Those Who Have Recovered From Infection: BHU Study
A new study conducted by Banaras Hindu University, has established that the first dose of the Covid-19 vaccine produces antibodies in those who have recovered from the disease within as short a timespan as 10 days
PTI
Jeevan Prakash Sharma
2021-05-05T11:03:00+05:30
Covid Vaccines Speed Up Production Of Antibodies In Those Who Have Recovered From Infection: BHU Study
outlookindia.com
2021-05-05T11:08:51+05:30
Also read
The research highlights the role and benefits of natural antibodies against the SARS-CoV-2 virus responsible for Covid.
The study has established that if a recovered person loses his antibodies after a few months of recovery, his memory cells help produce faster immunity in case of reinfection. ....

Uttar Pradesh , Gyaneshwar Chaubey , Sanjay Rai , Jayaprakash Muliyil , Anuradha Dube , Central Drug Research Institute , Indian Council For Medical Research , Indian Public Health Association , Serum Institute Of India , Banaras Hindu University , Prof Chaubey , Indian Council , Medical Research , Serum Institute , Covid 19 , Covid 19 Study , Vcovid 19 Antibodies , Covid 19 Vaccines , Covid 19 , Coronavirus India , Coronavirus Pandemic , Coronavirus Update , Coronavirus Deaths In India , Oronavirus Cases In India , New Coronavirus Cases In India , Coronavirus Treament ,

COVID-19 vaccination drive: Many challenges


ISSUE DATE: May 10, 2021
UPDATED: May 1, 2021 21:54 IST
People queue up to get Covid vaccine shots at an indoor
stadium in Guwahati, April 23, by David Talukdar / NURPHOTO
Beginning May 1, the Great Indian Vaccine Rollout will now cover millions of people in the 18-44 age bracket across the country in the inoculation drive against Covid-19. Except that the numbers are humongous and will be a lot more challenging than holding a general election or even taking a citizens’ headcount in the decadal Census. When it was launched on January 16, the phased rollout of the programme was in sync with the availability of Covid vaccines in the country. The first priority was the healthcare and frontline workers dealing with the pandemic. Then it was the turn of those above 60 years where mortality rates were the highest for the virus. So far, so good. The nation could easily meet the demand as vaccine hesitancy saw only half the numbers of the eligible group enrol. The ready ....

United States , United Kingdom , Uttar Pradesh , Andhra Pradesh , Tamil Nadu , Nirmala Sitharaman , Jayaprakash Muliyil , Narendra Modi , Zydus Cadila , Adar Poonawalla , Krishna Ella , Mahima Datla , Bharat Immunologicals Ltd , Indian Immunologicals Ltd , National Expert Group On Vaccine Administration , National Institute Of Epidemiology , National Covid , Serum Institute Of India , Haffkine Institute , Beginning May , Great Indian Vaccine Rollout , Prime Minister Modi , Serum Institute , Bharat Biotech , National Institute , Emerging Options ,

Opinions split on whether Delhi's cases have peaked


Opinions split on whether Delhi’s cases have peaked
Updated:
Updated:
Experts say current data not enough
Share Article
Experts say current data not enough
Expert opinion is divided on whether or not Delhi has reached its COVID-19 peak, even as the city continues to be ravaged by the pandemic with people on the hunt for oxygen and beds for relatives and friends.
The positivity rate, which is the percentage of people testing positive out of the total tests done, has been almost at the same level for the past week. There was a sharp rise in positivity from 3.5% on April 1 to 36.2% on April 22. But since then, it has stayed below it. ....

Tamil Nadu , Jayaprakash Muliyil , Giridharar Babu , Christian Medical College , Professor At Indian Institute Of Public Health , Community Medicine Department , Safdarjung Hospital , Indian Institute , Public Health , தமிழ் நாடு , கிறிஸ்துவர் மருத்துவ கல்லூரி , சமூக மருந்து துறை , சப்தர்ஜுங் மருத்துவமனை , இந்தியன் நிறுவனம் , பொது ஆரோக்கியம் ,